- Home
- KAVL vs BFRI Comparison
KAVL vs BFRI Comparison
Compare KAVL & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAVL
- BFRI
- Stock Information
- Founded
- KAVL 1998
- BFRI 1997
- Country
- KAVL United States
- BFRI United States
- Employees
- KAVL N/A
- BFRI N/A
- Industry
- KAVL Medicinal Chemicals and Botanical Products
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- KAVL Health Care
- BFRI Health Care
- Exchange
- KAVL Nasdaq
- BFRI Nasdaq
- Market Cap
- KAVL 7.9M
- BFRI 7.5M
- IPO Year
- KAVL N/A
- BFRI 2021
- Fundamental
- Price
- KAVL $0.49
- BFRI $0.71
- Analyst Decision
- KAVL
- BFRI Strong Buy
- Analyst Count
- KAVL 0
- BFRI 1
- Target Price
- KAVL N/A
- BFRI $2.75
- AVG Volume (30 Days)
- KAVL 27.8K
- BFRI 229.8K
- Earning Date
- KAVL 06-10-2025
- BFRI 08-13-2025
- Dividend Yield
- KAVL N/A
- BFRI N/A
- EPS Growth
- KAVL N/A
- BFRI N/A
- EPS
- KAVL N/A
- BFRI N/A
- Revenue
- KAVL $1,698,426.00
- BFRI $37,997,000.00
- Revenue This Year
- KAVL N/A
- BFRI $11.75
- Revenue Next Year
- KAVL N/A
- BFRI $17.09
- P/E Ratio
- KAVL N/A
- BFRI N/A
- Revenue Growth
- KAVL N/A
- BFRI 14.28
- 52 Week Low
- KAVL $0.46
- BFRI $0.54
- 52 Week High
- KAVL $3.02
- BFRI $2.22
- Technical
- Relative Strength Index (RSI)
- KAVL 36.39
- BFRI 45.79
- Support Level
- KAVL $0.49
- BFRI $0.61
- Resistance Level
- KAVL $0.56
- BFRI $0.66
- Average True Range (ATR)
- KAVL 0.03
- BFRI 0.05
- MACD
- KAVL -0.00
- BFRI 0.00
- Stochastic Oscillator
- KAVL 1.82
- BFRI 35.00
About KAVL Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.